Maryam Mahmood, M.B., Ch.B.

Open

• ICoN-1: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Efficacy and Safety of Clofazimine Inhalation Suspension When Added to Guideline-Based Therapy in Participants With Nontuberculous Mycobacterial Infection (Part A) Followed by an Open-Label Extension (Part B) Rochester, Minn.

  The purpsoe of this study is to compare the efficacy and safety of Clofazimine Inhalation Suspension versus placebo when added to guideline-based therapy (GBT)

  Mayo Clinic will not be participating in the optional PK sub-study.